FLUOXETINE CAPSULES

The Defense Logistics Agency awarded a firm-fixed-price delivery order to DMS PHARMACEUTICAL GROUP INC under base contract SPE2DX25D9900 for the procurement of 4.000 bottles of fluoxetine capsules, identified by NSN 6505013974313 and associated NDC codes 50111-0647-01, 00777-3104-02, and 77771-0113-01, at a unit price of $2.05 totaling $8.20. The delivery is scheduled for August 4, 2026, to Fort Campbell, Kentucky, with FOB destination terms placing all transportation and associated costs on the contractor. The contract specifies strict shipping requirements, including use of the fastest traceable means and prohibition of parcel post, with each shipment marked using the designated military recipient address. Packaging and labeling must include the NSN and manufacturer CAGE codes 3V8D7, 75602, and 8PNH3, along with NDC identifiers, though no specific MIL-STD packaging standards are cited. Inspection and acceptance occur at the destination by the government, with no explicit quality or testing criteria outlined beyond compliance with FDA-regulated pharmaceutical labeling. The awardee’s CAGE code is 1UNB0, and the NAICS code 424210 categorizes the business as a pharmaceutical and medicine merchant wholesaler, though no socioeconomic status, size certification, or affirmative representations are documented. Payment is contractor-funded under FOB destination, with DIC code A0A and PR number 7017562419 referenced for financial processing, though no formal invoicing method or payment office details are provided. No contract clauses, evaluation factors, special requirements, or attachments are explicitly included in the documentation, indicating this is a streamlined, low-value supply transaction under an existing logistics contract vehicle with minimal administrative detail beyond logistical execution requirements.